Thomas H. Watkins's most recent trade in Horizon Therapeutics Plc was a trade of 3,913 Restricted Stock Units done . Disclosure was reported to the exchange on April 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Plc | Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 29,124 (0%) | 0% | - | Ordinary Shares | |
| Vanda Pharma Inc | Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharma Inc | Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.15 per share. | 02 Jun 2022 | 15,000 | 69,505 (0%) | 0% | 4.2 | 62,250 | Common Stock |
| Vanda Pharma Inc | Thomas H. Watkins | Director | Sale of securities on an exchange or to another person at price $ 9.90 per share. | 02 Jun 2022 | 6,441 | 63,064 (0%) | 0% | 9.9 | 63,779 | Common Stock |
| Horizon Therapeutics Plc | Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 75,164 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Thomas H. Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 3,913 | 3,913 | - | - | Restricted Stock Units | |
| Vanda Pharma Inc | H. Thomas Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharma Inc | H. Thomas Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 54,505 (0%) | 0% | 0 | Common Stock | |
| Horizon Therapeutics Plc | H. Thomas Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | H. Thomas Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 70,941 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | H. Thomas Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,223 | 4,223 | - | - | Restricted Stock Units |